Caribou Biosciences (CRBU) Other financing activities (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Other financing activities came in at $468000.0 in Q1 2026, little changed year-on-year from $468000.0 in Q1 2025, and up 68.95% on a QoQ basis from $277000.0 in Q3 2025.
Caribou Biosciences (CRBU) Other financing activities (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 6 years of Other financing activities data on file, last reported at $468000.0 in Q1 2026.
- On a quarterly basis, Other financing activities changed 0.0% year-over-year to $468000.0 in Q1 2026; TTM through Mar 2026 was $745000.0, a 4.2% increase from a year earlier, with the FY2025 full-year figure at $745000.0, down 18.49% from the prior year.
- Other financing activities for Q1 2026 stood at $468000.0, up from $277000.0 in the prior quarter.
- Over the last five years, Other financing activities for CRBU reached as high as $17.4 million in Q2 2023 and fell as low as -$17.4 million in Q3 2023.
- Historically, Other financing activities has averaged $1.9 million across 4 years, with a median of $372500.0 in 2025.
- On a YoY basis, Other financing activities climbed as much as 101.4% in 2024 and fell as far as 99.99% in 2024.
- Year by year, Other financing activities stood at $17.3 million in 2023, then tumbled by 99.99% to $1000.0 in 2024, then soared by 27600.0% to $277000.0 in 2025, then soared by 68.95% to $468000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $468000.0 in Q1 2026, $277000.0 in Q3 2025, and $468000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 468,000.00 |
| Mar 31, 2026 | 468,000.00 |
| Sep 30, 2025 | 277,000.00 |
| Sep 30, 2025 | 277,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 244,000.00 |
| Sep 30, 2024 | 244,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 667,000.00 |
| Mar 31, 2024 | 667,000.00 |
| Dec 31, 2023 | 17.29 Mn |
| Dec 31, 2023 | 17.29 Mn |
| Sep 30, 2023 | -17.45 Mn |
| Sep 30, 2023 | -17.45 Mn |
| Jun 30, 2023 | 17.45 Mn |
| Jun 30, 2023 | 17.45 Mn |